Table 3 Study drug administration details
Total cycles administered | 443 |
Number of cycles per patient (median (range)) | 6 (1–17) |
Cumulative PLD dose (mg m−2) (median (range)) | 227 (36–630) |
Cumulative GEM dose (mg m−2) (median (range)) | 13 600 (1200–36 800) |
Patients with dose reduction (no. (%)) | 10 (14.5%) |
Patients with treatment delay (no. (%)) | 10 (14.5%) |
Patients discontinuing treatment owing to toxicity (no. (%)) | 6 (8.7%) |
